Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5219_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •1.1 Introduction
- •1.2 Conventional Methods
- •1.2.1 Microscopy
- •1.2.2 Culture
- •1.2.3 Germ Tube Test
- •1.2.5 Carbohydrate Assimilation Test
- •1.2.6 Nitrogen Assimilation Test
- •1.2.7 Carbohydrate Fermentation Test
- •1.2.8 Urease Test
- •1.2.9 Tween 80 Opacity Test
- •1.3 Nonculture-Based Conventional Methods
- •1.3.1 Serological Methods
- •1.3.1.2 ß-d-Glucan
- •1.3.1.3 C. albicans Germ Tube Antibody Assay (CAGTA)
- •1.4 Nucleic Acid-Based Detection
- •1.4.1 Polymerase Chain Reaction (PCR)
- •1.4.3 Peptide Nucleic Acid FISH (PNA-FISH)
- •1.4.4 PCR-Based Innovative Diagnosis
- •1.4.5 FilmArray System
- •1.4.6 Sepsis Flow Chip
- •1.4.7 ePlex System
- •1.4.8 The T2 Candida Assay
- •1.5 Rapid Identification Systems
- •1.5.1 Manual Rapid Identification System
- •1.5.1.1 The API System
- •1.5.1.2 The VITEK System
- •1.5.2 Automatic Rapid Identification System
- •1.5.2.1 MALDI-TOF MS
- •1.5.2.2 The MALDI Sepsityper IVD Kit
- •1.5.2.3 The BioFire FilmArray BCID2 Panel
- •1.5.2.4 The Accelerate Pheno BC Panel
- •1.6 Advanced Diagnostics
- •1.6.2 Biosensor-Based Tests
- •1.6.3 Next-Generation Sequencing (NGS)
- •1.7 Conclusion
- •References
- •2.1 Introduction
- •2.2.1.2 Echinocandins
- •First-Generation Echinocandin
- •Second-Generation Echinocandin
- •2.2.1.3 Other Cell Wall Inhibitors
- •2.2.2.1 Azoles
- •Imidazole
- •Triazole
- •Second-Generation Azole
- •Third-Generation Azole
- •2.2.2.2 Polyenes
- •Other Polyene Under Development
- •2.2.2.3 Allylamines
- •2.2.3 Flucytosine
- •2.3 Conclusion
- •References
- •3.1 Introduction
- •3.2.1 Control Diet
- •3.2.3 Toxification
- •3.2.4 Alternative Treatments
- •3.3.1 Prophylaxis
- •3.3.2 Preemptive Therapies
- •3.3.3 Empirical Therapies
- •3.4 Therapeutic Approach
- •3.4.1 Azoles
- •3.4.2 Echinocandins
- •3.4.3 Polyenes
- •References
- •4.1 Introduction
- •4.3 Eukarya Domain
- •4.4.1 Cryptococcus
- •4.4.2 Aspergillus
- •4.4.3 Mucorales
- •4.4.4 Candida
- •4.5.1 Candida albicans
- •4.5.2 Morphogenesis
- •4.5.3 Pathogenesis
- •4.5.4 Adherence
- •4.5.5 Morphological Switching
- •4.5.6 Invasion
- •4.6 Induced Endocytosis
- •4.7 Active Penetration
- •4.8.2 Biofilm Formation
- •4.8.4.1 Antifungals
- •4.8.4.2 Antifungal Resistance
- •References
- •5.1 Introduction
- •5.2.3.1 Serum
- •5.2.3.2 Low Nitrogen
- •5.2.3.5 Carbon Source
- •5.2.3.6 pH
- •5.2.3.7 N-acetylglucosamine (GlcNAc)
- •5.2.3.8 Quorum Sensing Molecule
- •5.5.5 Surface Colonization Factor1 (SCF1)
- •5.5.6 Other Putative Adhesins
- •5.6.1 Phospholipases
- •5.6.2 Proteinases
- •5.6.3 Hemolysins
- •5.6.4 Lipases
- •5.7 Secreted Cytolytic Peptide: Candidalysin
- •5.5.1 ALS Family
- •5.5.2 HWP Adhesin
- •5.5.3 HYR/IFF Family
- •5.5.4 EPA Family
- •5.9.2 Low Molecular Weight Hsp/Small Heat Shock Proteins
- •5.10.1 Amino Acid/Nitrogen Metabolism
- •5.10.1.1 Amino Acid Sensing Pathway
- •5.12.1.1 Glycolysis
- •5.12.1.2 Gluconeogenesis
- •5.12.1.3 Glyoxylate Cycle
- •5.12.1.4 Fatty Acid Oxidation
- •5.12.3.2 Iron Metabolism
- •5.12.3.3 Candida Iron Transport
- •5.12.3.4 Reductive System
- •5.12.3.5 Siderophore Uptake System
- •5.12.3.6 Haemoglobin-Iron Uptake System
- •5.13.2 Zinc Metabolism
- •References
- •6.1 Introduction
- •6.2 Morphological Switching
- •6.3 Phenotypic Switching
- •6.4 Biofilm Formation
- •6.5 Metabolic Flexibility
- •6.8.1 Hemolysin
- •6.8.2 Phospholipases
- •6.8.3 Proteinase
- •6.8.4 Candidalysin
- •6.12 Conclusion
- •References
- •7.1 Introduction
- •7.2.4 Polymorphism
- •7.2.5.1 Secreted Aspartyl Proteinases
- •7.2.5.2 Phospholipase
- •7.2.6 Calcineurin-Signalling Pathway
- •7.2.7 Ion Homeostasis
- •7.2.7.1 Iron
- •7.2.7.2 Copper
- •7.2.8.1 Capsule
- •7.2.8.2 Melanin
- •7.2.8.3 Heat Shock Proteins
- •7.3 Conclusions
- •References
- •8.1 Introduction
- •8.4.1 ATP-Binding Cassette (ABC) Transporters
- •8.4.2 Major Facilitator Superfamily (MFS) Transporter
- •8.5.1 Biofilm Architecture Among Candida Species
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3 Biofilm
- •10.5 Adherence
- •10.6 Maturation
- •10.8 Dispersion
- •10.11 Animal Models
- •10.18 Photodynamic Therapy
- •References
- •11.1 Introduction
- •11.9 Concluding Remarks
- •References
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3.1 Humoral Response
- •12.3.2 Cellular Immunity
- •12.4 Virulence Factors
- •12.6.1 Fluconazole
- •12.6.2 Polyenes
- •12.6.3 Echinocandins
- •12.7 Drug Resistance
- •12.8 Future Prospects
- •12.9 Conclusions
- •References
- •13.1 Introduction
- •13.4 Translation Research
- •13.4.1 Disease-Oriented Translational Research
- •13.4.2 Lab-Oriented Translational Research
- •13.4.3 Patient-Oriented Translational Research
- •13.5 Conclusion
- •References
- •14.1 Introduction
- •14.2.3 Cutaneous Aspergillosis
- •14.2.4 Ocular Aspergillosis
- •14.2.5 Aspergillus Endocarditis
- •14.2.6 Aspergillus Osteomyelitis
- •14.2.7 Sinus Aspergillosis
- •14.3.2 Histopathology
- •14.3.3 Serological
- •14.3.4 Breath Testing
- •14.3.5 Monoclonal Antibody (mAbs)-Mediated Methods
- •14.4.1 Conventional Therapeutics
- •14.4.1.1 Azoles
- •14.4.1.2 Polyenes
- •14.4.1.3 Echinocandins
- •14.4.1.4 Fluoropyrimidines
- •14.5 Nonconventional Therapeutics
- •14.5.1 Vaccine
- •14.5.2 Monoclonal Antibodies (mAbs)
- •14.5.3 Nanotechnology-Based Therapeutics
- •14.5.4 Immune Therapy
- •14.5.5 Combination Therapy
- •14.8 Conclusion
- •References
- •15: Aspergillus Therapeutics: Future Agents
- •15.1 Introduction
- •15.2.1 Fosmanogepix
- •15.2.2 Ibrexafungerp
- •15.2.3 Olorofim
- •15.2.4 Opelconazole
- •15.2.5 Rezafungin
- •15.2.6 MGCD290
- •15.2.7 Tetrazoles (VT-1129/VT-1161/VT-1598)
- •15.2.8 Nikkomycin Z
- •15.2.9 VL-2397
- •15.2.10 T-2307/ATI-2307
- •15.2.11 Encochleated Amphotericin-B
- •15.2.12 SUBA-Itraconazole
- •15.2.13 Immunotherapy
- •15.2.14 Drug Repurposing
- •References
- •16.1 Introduction
- •16.2 Antifungal Agents
- •16.2.1 Azoles
- •16.2.2 Posaconazole
- •16.2.3 Isavuconazole
- •16.2.4 SUBA—Itraconazole
- •16.2.5 Nanovoriconazole
- •16.2.6 Adverse Effects
- •16.3 Liposomal Amphotericin B (LAMB)
- •16.3.1 Echinocandins
- •16.4 Combination Antifungal Therapy
- •16.5 Therapeutic Drug Monitoring (TDM)
- •16.5.1 Azole-Resistant Aspergillus Spp.
- •16.6 Guideline Recommendations
- •16.10 Conclusion
- •References
- •17.1 Introduction
- •17.3 Potent Antifungal Molecules Under Investigations
- •References
- •19.2 Host–A. fumigatus Interactions
- •19.3.1 Hydrophobicity or Rodlet Layer
- •19.3.2 Conidiation
- •19.3.3 DHN Melanin
- •19.3.5 Siderophores
- •19.3.6 Biofilm Formation
- •19.4 Conclusion
- •References

158
S. Sahoo and K. H. Rao
6.1 Introduction
Candida is a diploid fungus that causes mucosal and systemic infections in humans.
The fungi reside in both people and animals as natural ora, but it may become
opportunistic, causing crippling and deadly infections (Vincent 2009). Candida species can colonize a variety of anatomical locations. Candida infections are characterized as supercial, cutaneous, mucosal, or systemic (deep and broad). Invasive
candidiasis is an infection that causes highly serious illnesses such as “candidemia
(blood infection), meningitis (brain infection), and endocarditis (heart infection)”
(De Rosa etal. 2009). While Candida albicans is responsible for around 50% of
candidiasis, the remaining Candida infection is caused by non-albicans Candida
species. Candida tropicalis, Candida glabrata, Candida parapsilosis, Candida kru-
sei, Candida dubliniensis, and Candida auris infection are all major concerns.
Some of these Candida species are currently considered as emergent opportunistic
pathogens.
Pathogenesis of Candida species is a complicated process involving several
mechanisms and pathways. It is also a complicated and multifaceted process that
involves both host and microbe characteristics. To develop infection, the opportunistic pathogen must elude detection, proliferate in the host environment, and thrive
in the host immune system. The organism additionally needs to spread to different
bodily tissues and organs, which is especially important in systemic infection. Skin
or gastrointestinal barrier disruption can result in widespread or deep organ candidiasis. In more catastrophic cases, bloodstream infection may occur, which would
then spread to other organs of the body. Most Candida infections are asymptomatic.
This is owing to the immune system’s capacity to impede the organism as it seeks
to propagate throughout the body. However, immune system depletion or alterations
in microbiota balance, when combined with other circumstances, can aid in the
spread of Candida, which is typically deadly in 42% of reported instances (Dadar
et al. 2018). Several variables are involved in the pathogenesis of Candida spp.
“Multiple transcriptional circuits, morphological and phenotypic switching, biolm
formation, tissue-damaging extracellular hydrolytic enzymes, metabolic exibility,
genome plasticity, adaptation to environmental pH uctuation, robust nutrient
acquisition system, adherence and invasions (mediated by adhesins and invasins),
heat shock proteins (HSPs), cytolytic proteins, phagocytosis escape, evasion of host
immune responses, and in tandem coaggregation with microbiota” are shown in
Fig.6.1. This chapter is solely based on an extensive analysis of the literature on the
processes of Candida pathogenesis, with a focus on the pathogenic factors and virulence of the organism.
6.2 Morphological Switching
The transition of Candida albicans from the commensal yeast form to the invasive
hyphal shape is linked to the organism’s pathogenicity (Jacobsen and Hube 2017).
C. albicans lamentation is initiated by thigmotropism, or touch sensing, upon host

6 Molecular Cues andMechanisms ofPathogenesis inCandida
Fig. 6.1 Various pathogenic determinants of fungal pathogen Candida
159
cell attachment. By secreting extracellular enzymes, fungi are enabled to enter the
host tissues more deeply (Aoki etal. 2011). Dimorphism is the capacity of Candida
to change from the yeast to the hyphae phase or vice versa. Due to their respective
effects on how Candida evades the immune system, each of these development
stages is essential for virulence and pathogenicity. During disseminated candidiasis,
the lament (hyphae) and yeast forms have separate functions. The hyphal (lamentous) form is engaged in tissue invasion and pathogenesis, whereas the yeast form is
involved in dispersion (Seman etal. 2018). In the development of candidiasis, particularly candidemia, the ease with which hyphae inltrate the mucosal membrane,
tissues, and enter the circulation is crucial (Koh etal. 2008). Although within a
narrow range of circumstances, Candida albicans, Candida tropicalis, Candida
dubliniensis, and more recently, Candida auris have all been found to generate
hyphae (Kornitzer 2019). But most other species of Candida, such as C. glabrata,
only produce yeast and pseudohyphae. Some of the environmental factors that
encourage yeast to hyphal transition include incubation in serum, alkaline, or neutral pH, low oxygen concentrations, elevated CO2, cell density via quorum- sensing
molecules, carbon, and nitrogen deciency (Sudbery 2011). Interestingly, hyphal
morphogenesis may also be induced in the absence of an external stimulation
(Kornitzer 2019). Nonetheless, it has been demonstrated that several transcription
factors (TFs) affect hyphae growth. Tup1, Ngr1, Rim101, Cph2, Cph1, Czf1, Efg1,
Tec1, Flo8, Ume6, Fkh2, and Mcm1 are a few of the TFs that have been shown in
Fig.6.2. According to Desai etal. (2015), the primary TF genes needed for hyphal
invasion include ERG1, TEC1, NDT80, ROB1, DPB4, and EFG1. Except for

160
Fig. 6.2 Proteins and transcription factors, directly and indirectly, responsible for the change and
help in the pathogenesis of Candida spp. Red highlighted are transcription factors (TF) whereas
black are proteins
S. Sahoo and K. H. Rao
Ume6, most TFs are necessary for hyphal development in favorable circumstances,
although their expression alone may not always be sufcient to inuence actual
hyphal morphogenesis. However, Banerjee et al.’s investigation showed that in
C. parapsilosis and C. tropicalis, hyphae production results in lower virulence and
pathogenesis (Banerjee et al. 2019). The study recommends that non-albicans
Candida could be investigated independently to fully understand the primary role
and causes of lamentation.
6.3 Phenotypic Switching
Understanding the processes governing the phenotypic switching system can help
explain how pathogenic Candida spp. can adapt, survive, and reproduce in a variety
of host environments. It is still unclear, why C. albicans incorporate morphological
switching into their sexual life cycle. MTL homozygous Candida spp. must change
from normal yeast cell morphology to an opaque cell to mate (Johnson 2003).
Several signals greatly aid in this process (Alby and Bennett 2009). As soon as the
signals become dominant, the phenotypic switch activates, which can result in the
development of invasive bloodstream infections as well as supercial infections of
the skin and mucosa, particularly in those with compromised immune systems.

6 Molecular Cues andMechanisms ofPathogenesis inCandida
161
Solis etal. (2018), noted that opaque cells, like white cells, demonstrated diminished invasive capacity and decreased ability to harm epithelial cells as a result of
diminished surface expression of invasins and an inability to stimulate the receptors
of epidermal growth factor. Another morphological switching mechanism that has
been identied in C. albicans is the white-gray opaque phenotype (Tao etal. 2014).
It has been established that C. albicans’ phenotypic ipping mechanism promotes
tness, provides an adaptation advantage, and serves a number of biological functions in cells that express it. WOR1, which encodes a TF, controls phenotypic ipping. The white phase is the default phenotype. The TFs Czf1, Efg1, Wor2, Wor1,
Ahr1, and Wor3 responsible for controlling WOR1 are marked in Fig.6.2. Research
has demonstrated that white phenotypes are more virulent than opaque phenotypes.
This is because polymorphonuclear (PMN) cells cannot be attracted to opaque cells
by chemoattractants (Soll 2014). In general, the transition promotes host colonization and mating. Pathogenesis and virulence are signicantly inuenced by phenotypic switching. Depending on the surroundings, it allows C. albicans to evade
detection by immune system cells (Sasse etal. 2012). White-opaque ipping in
C. tropicalis was discovered to alter host-pathogen interactions in an infection system in a recent research by Perini etal. (2019). Comprehending the regulation and
control mechanism of phenotypic ipping may be essential in addressing the reasons behind pathogenic Candida species’ ability is to adjust and endure in various
unfavorable environments.
6.4 Biofilm Formation
One of the main virulence factors of Candida spp. is biolm. Most infections linked
to Candida entail the production of biolms. Through their adhesins, yeast cells
cling to both other cells and the substrate. The cells multiply to create microcolonies. The germ tube, pseudohyphae, and hyphae come next. Biolm biomass
increases together with the production and buildup of extracellular matrix (ECM)
throughout maturation. Ultimately, the yeast cells spread out and start to produce
new biolms. Candida’s capacity to colonize is enhanced by the production of biolms. Additionally, it shields the cell from immunological harm, particularly from
neutrophils, and inhibits the production of reactive oxygen species (ROS), which is
highly harmful to the organism (Xie etal. 2012). Biolm production has signicant
therapeutic implications because of the cells’ resistance to immunological harm,
resistance to antifungal medications, and capacity to survive when encased in the
ECM (Silva etal. 2017). Moreover, efux pump transporters are induced by Candida
biolms (Taff etal. 2012). During biolm development, there is a decreased sensitivity to antimicrobials due to three different reasons:
1. The medication’s incapacity to penetrate the biolm’s extracellular polysaccha-
ride matrix.
2. The drug’s antagonistic effects are brought on by waste product buildup and
nutritional depletion.

162
S. Sahoo and K. H. Rao
3. The fungi’s altered physiological state.
C. albicans is more frequently linked to biolm production. Nonetheless, recent
research has demonstrated that non-albicans Candida spp. has a high rate of biolmforming capacity (Subramanya etal. 2017). Biolms can be formed by Candida
glabrata, Candida tropicalis, Candida parapsilosis, and Candida auris (Sherry
etal. 2017). Candida is inhibited by proteins such as lactoferrins, lysozyme, secretory IgA, and mucin, which prevents adherence and proliferation on the mucosal
surface (Pereira-Cenci etal. 2008). Biolm development and structural stability are
enhanced by the presence of additional polymeric components and Candida hyphae
(Pereira-Cenci etal. 2008). Hyphae-associated genes are among the genes that regulate the production of biolms. Most genes have diverse roles. Several TFs control
the process as well. In Candida albicans, the primary TFs are “Ndt80, Rob1, Gal4,
Rfx2, Flo8, Efg1, Brg1, Tec1, and BCr1” as shown in Fig.6.2.
6.5 Metabolic Flexibility
One essential requirement for the survival and development of Candida infection is
the metabolic ability to digest host resources, specically carbon. This capability
must be managed. One signicant virulence element that gives Candida spp. adaptive benets is metabolic exibility. One of the regular behaviors linked to Candida
albicans in the gastrointestinal system is competition for resources with the host
microbiota. Depending on the anatomical location, Candida spp. employ different
nutrition sources during infection. C. albicans and other species use host-derived
lipids, proteins, amino acids, and glucose (Sahoo etal. 2023) as nutrition. In general, Candida uses many metabolic pathways to break down its nutrients.
Colonization and virulence are decreased when any of the pathway’s stages are
disrupted. Different carbon sources—both sugar and nonsugar—are utilized during
infection. Candida species have the capacity to use GlcNAc to adjust and increase
pH and hyphal development (Sahoo etal. 2023). Thus, metabolic exibility gives
virulence an advantage. It has been documented that increases in lactate and carboxylic acids cause signicant alterations to the cell wall of C. albicans by hiding
β-glucans, a useful strategy for immune evasion (Danhof et al. 2016).
Gluconeogenesis, the glyoxylate cycle, and the β-oxidation of fatty acids are often
elevated during invasive infections. Above all, the glyoxylate route is an important
metabolic process found in Candida species that is necessary for survival under
harsh environmental circumstances such as nutrient starvation. When C. albicans is
phagocytosed by immune cells, it starves nutrients. The organism moves from glycolysis to gluconeogenesis and then to the glyoxylate cycle when C. albicans is
fully engulfed in the macrophages. The two key glyoxylate cycle enzymes, malate
synthase and isocitrate lyase, completely facilitate this transition. Because of this
change in the route, C. albicans may grow in phagocytic cells—such as neutrophils
and macrophages—that are devoid of all nutrients (Dunn etal. 2009). The glyoxylate cycle is necessary for both the virulence and survival of Candida when it is taken

6 Molecular Cues andMechanisms ofPathogenesis inCandida
163
up by neutrophils and macrophages (Lorenz and Fink 2001). Lately, Laurian and
colleagues delved into the hitherto unexplored facets of glycolytic metabolism in
Candida, demonstrating the signicance of hexokinase and glucokinases in morphological change, cell tness, and their role in mediating virulence and pathogenicity (Laurian etal. 2019). According to a review by Fourie etal. (2018), iron
levels signicantly affect C. albicans’ capacity to transform from a commensal to a
pathogen. The course of disease is also signicantly inuenced by iron. In order to
survive in the host, Candida glabrata also makes use of viable substitute carbon
sources (Chew etal. 2019). A key factor in Candida spp. pathogenicity is their
capacity to adapt to host-induced variations in nutrition availability.
6.6 Cooperative Coaggregation withtheLocal Microbiome
To preserve relative equilibrium, the intricate community of bacteria has coevolved
through interactions among them (Belkaid and Harrison 2017). Candida species
coexist in high concentrations with various human bacterial microbiota. In close
proximity, fungal cells can be supported by or interfered with bacteria, and vice
versa. A healthy microbiome depends on the relationships and interactions between
microorganisms. A change in the way microbes interact results in the overgrowth of
Candida species. This frequently has a major detrimental impact on people’s health,
particularly in those who are immunocompromised. Strong interactions between
bacteria and C. albicans directly affect the pathophysiology and treatment of fungal
infections. About 25% of bacterial infections frequently coexist with bloodstream
infections caused by Candida. The two main bacteria that are most frequently identied from C. albicans infections are Pseudomonas aeruginosa and Staphylococcus
(mostly aureus and epidermidis). When two microbial species (C. albicans and
Streptococcus mutants) aggregate during the biolm formation process, the resulting biolms frequently have a larger biomass and mutual advantages compared to
biolms generated by a single species (Lobo etal. 2019). In oropharyngeal candidiasis, the association between the hyphae of C. albicans and C. glabrata promotes
the growth of C. glabrata (Tati et al. 2016). As Staphylococcus aureus invades
mucosal barriers, it clings to the hyphae that C. albicans forms. S. aureus produces
a biolm that makes Candida more pathogenic. Additionally, it shields the bacterium from antimicrobial drugs and host immune cells (Schlecht etal. 2015).
Certain types of bacteria can colonize an area and lessen the pathogenicity and
burden of Candida. According to a recent research, E. coli not only dominates
C. albicans but also secretes a chemical that, in a manner reliant on magnesium,
kills Candida cells (Cabral etal. 2018). Staphylococcus aureus and C. glabrata have
an antagonistic relationship, as shown by Camarillo-Màrquez etal. (2018). The
information demonstrated that S. aureus induced cell death through an apoptotic
mechanism and inhibited the growth of C. glabrata. De Barros etal. 2018 have
demonstrated that C. albicans is negatively impacted by C. tropicalis biolm devel-
opment, yeast-to-hyphae transition, and changes in its virulence properties.
Antibiotic-induced bacterial depletion can mitigate lamentation repression caused

164
by bacteria, which will allow Candida to switch from a commensal to a pathogenic
state more easily. Comprehending the molecular connections among bacteria,
Candida, and the host is crucial since these interactions signicantly impact the
course of the disease.
S. Sahoo and K. H. Rao
6.7 Secretion ofHeat Shock Proteins
The majority of microorganisms include heat shock proteins (Hsps), which are typically generated in response to osmotic pressure, pH stress, oxidative and thermal
stress, and nutritional decits (Tiwari etal. 2015). To stop polypeptides from aggregating and misfolding, Hsps function as molecular chaperons, which are proteins
that bind and recognize developing polypeptides and partly folded protein intermediates. Heat shock TF (Hsf1) is phosphorylated in response to environmental perturbations, including thermal stress, which initiates signalling pathways (Cuéllar-Cruz
etal. 2014). Hsp genes are expressed as a result of Hsf1 being phosphorylated.
Several Hsp genes are aided in their expression by the heat shock element (HSE)
(Nicholls etal. 2009). The overall pathogenicity of Candida spp. and several cellular functions are signicantly impacted by this gene expression. The Efg1 gene and
a number of TFs, notably those involved in the production of hyphae and biolms,
are also induced by the signalling pathways. The expression of this gene is very
inuential on several cellular processes, leading to higher pathogenicity and virulence in the end. Hsps confers resistance to antifungal drugs by modulating signalling pathways (Li and Sun 2016). In C. albicans, six HSPs linked to pathogenesis
have been identied: HSPs 90, HSP 60, HSP 21, HSP 104, HSP 12, and HSP 70
(Jaya etal. 2009). Their functions have been elucidated in Table6.1.
6.8 “Extracellular Hydrolytic Enzymes andProteins”
6.8.1 Hemolysin
The adaptability and longevity of harmful microbes depend on how easily they can
acquire iron. Since the host does not contain any free iron molecules, hemoglobin is
a common complex containing iron. Hemolysins are lytic proteins that help in
hemoglobin breakdown and release of iron (Eduardo etal. 2007). Hemolysins are a
highly signicant virulence factor because of their extraordinary capacity to promote pathogen survival and persistence as a result of iron acquisition, hyphal invasion in instances of systemic candidiasis, or disseminated candidiasis (Rossoni etal.
2013). C. albicans as well as non-albicans shows Beta-hemolysis (complete) (Chin
etal. 2013). Sachin etal. (2012) observed that C. albicans produces hemolysin at a
high rate (94.8%). The level of blood glucose, the availability of electrolytes, and
the genotype of the Candida strain are few of the variables that affect the formation
of hemolysin. The three electrolytes—CaCl2, NaCl, and KCl—can reduce hemolysin synthesis in Candida species (Wan etal. 2015). On the other hand, Arslan etal.

6 Molecular Cues andMechanisms ofPathogenesis inCandida
Table 6.1 Function of different HSPs that affect the pathogenesis of Candida species
HSPs
Hsp 90 Associated with drug resistance, morphological change, heat
Hsp 70 Ssa1 and Ssa2 are the two members that are visible in C. albicans.
Hsp 60 Primarily engaged in immune responses Mba and
Hsp 12
(small
Hsp)
Hsp 21
(small
Hsp)
Function
tolerance, and cell cycle control
Regulates the growth of yeast cells. Interacts with calcineurin to
cause the shift from mycelia to yeast
Activate the genes that suppress Ras1-pka signalling to adversely
affect the yeast-to-hyphae transition
Downregulation starts the Ras1-pka pathway, which is crucial for
the formation of hyphae
They signicantly impact the pathogenicity of C. albicans by
inducing endocytosis of the host cells. These outcomes may be
favorable or unfavorable
Increases yeast cell adhesion, cell proliferation, and reduces C.
albicans’ sensitivity to farnesol
Maintains the “homeostasis of glycerol, trehalose, and glycogen” Mayer etal.
Reference
O’Meara and
Cowen (2014)
Tiwari etal.
(2015)
Shapiro and
Cowen (2010)
Mishra etal.
(2017)
Sun etal.
(2010)
Nweze (2020)
Fu etal.
(2012)
(2012)
165
(2016), demonstrated that carries and diabetes do not affect Candida virulence.
Hemolysins’ precise function in fungal infection is unclear, in contrast to other
enzymes (Wan etal. 2015).
6.8.2 Phospholipases
The hydrolases known as phospholipases are widely distributed and are responsible
for the hydrolysis of phospholipids into fatty acids and other lipophilic compounds.
These are a very signicant and diverse collection of hydrolytic enzymes that break
the ester bonds in phospholipids, allowing organisms to enter the host cell and cause
cell lysis. The synthesis of phospholipases might be considered one of the primary
markers to differentiate virulent invasive strains of Candida species from noninvasive strains, given its extensive function in systemic infection. Typically, C. albicans
is the most effective phospholipase producer. Phospholipase production has been
reported from a variety of Candida species, including C. glabrata, C. tropicalis,
C. krusei, and even C. parapsilosis (Pandey etal. 2018). Phospholipases (A, B, C,
and D) are the four types of phospholipases (Yang 2003). It is known that B1 and
B2 both contribute to the host cell’s demise (Naglik etal. 2003). Seven phospholipasecoding genes have been linked to C. albicans: PLA, PLB1, PLB2, PLC1, PLC2,
PLC3, and PLD1.

166
S. Sahoo and K. H. Rao
6.8.3 Proteinase
An essential enzyme called proteinase cleaves or degrades essential proteins.
“Serine proteinase, aspartyl proteinase, cysteine proteinase, and metalloproteinase”
are the four types of proteinases. Secretory aspartyl proteinases (SAP) are secreted
by Candida. One of the multifunctional elements implicated in the pathophysiology
of Candida is SAP.Fungi that produce SAP improve host tissue colonization and
penetration. SAP is one of the main criteria for various forms of candidiasis because
the expression of distinct SAP genes corresponds with disease types (Meenambiga
etal. 2018). It breaks down proteins in host tissues, promotes adhesion to epithelial
host tissues (Kadry et al. 2018), improves dissemination, and promotes biolm
development and phenotypic switching. Through its capacity to break down many
proteins “complements, cytokines, and immunoglobulin,” which are necessary for
host defense, the fungus protects from the immune system. In C. albicans, SAP
genes extending from SAP1 to SAP10 have been discovered (Borelli etal. 2008).
According to de Souza Ramos etal. (2015), the majority of non-albicans and all
C. albicans isolates from cutaneous candidiasis patients generate SAP. Highly
pathogenic Candida species that are commonly reported to generate SAP include
C. glabrata, C. tropicalis, C. parapsilosis, C. dubliniensis, and C. albicans (Naglik
etal. 2003).
6.8.4 Candidalysin
Candidalysin is a cytolytic toxin that is generated by C. albicans. It is an amino acid
peptide. Non-albicans like C. tropicalis and C. dubliniensis also generate a cytotoxic protein that is comparable. The Ece1p protein secretes candidalysin. One of
the main morphology-associated genes in C. albicans, ECE1, is typically expressed
during hyphae development (Moyes etal. 2016). Candidalysin can penetrate the
host epithelium and cause lysis. It triggers the activation of epithelial immunity and
triggers a danger response signalling pathway. It is essential for the immunopathology of mucosal infections. It has recently been shown that candidalysin is also necessary when C. albicans spreads throughout the body (Swidergall etal. 2019). It is
now understood that a critical process that amplies mucosal Candida infection and
expedites the course of the disease is the synthesis of candidalysin. By means of the
epidermal growth factor receptor (EGFR), candidalysin triggers innate epithelial
immune responses, as demonstrated by Ho etal. (2019). Lactate dehydrogenase is
produced in response to candidalysin (Moyes etal. 2016), a sign of membrane rupture and cell damage. Moreover, candidalysin uses MAPK signalling molecules to
induce epithelial immunity, which inevitably promotes the immune cell recruitment
necessary for defense over mucosal infection (Moyes etal. 2016). Moreover, it
starts the NLRP3 inammasome, which causes phagocytes to undergo cytolysis.
For the treatment of mucosal infections, candidalysin and the related signalling
components may prove to be effective therapeutic targets.

6 Molecular Cues andMechanisms ofPathogenesis inCandida
167
6.9 Adjustment toVariations inpH
The pH of the environment affects Candida’s survival. The intake of nutrients (such
as iron) necessary for innate immunity and other essential processes is interfered by
the pH shift. However, in Candida species, alterations in pH cause the production of
PHR1 and PHR2 genes and initiate signalling pathways, which enable the organism
to detect pH changes (Nadeem etal. 2013). Candida pathogenesis requires adaptation to changing ambient pH levels. Alkalinity causes morphological alterations,
lamentation, and even the development of fruiting bodies in most of the pathogenic fungus (Vylkova 2017). Alkalinity promotes tissue penetration and aids in
cells’ ability to evade immune cell activity. Ammonia (NH3) is produced by C. albi-
cans to maintain internal pH.Urease is an enzyme that converts NH3 to NH
the course of exporting NH3 out of the cell. It has been demonstrated that morphogenesis is facilitated when the pH rises due to an increase in the amount of NH
the environment. Additionally, it allows the fungus to avoid being attacked by macrophages and phagosomes (Westman etal. 2018). According to recent research by
Rane etal. (2019), Pma1p, the primary regulator of cytosolic pH in fungi, is crucial
for cytosolic alkalinization as well as proliferation, lamentation, pH homeostasis,
and a general rise in C. albicans virulence.
An acidic environment promotes the release of a highly effective pathogenic factor called SAP, which also protects Candida species. Candida’s ability to adapt and
survive in an acidic environment is crucial for essential cellular processes including
morphogenesis, mating, and phenotypic switching. C. albicans growing in an acidic
environment contains more chitin and β-glucan in its cell wall. Because of the acidity, the cell wall remodels, which improves colonization by increasing immune cell
recognition of C. albicans and triggering proinammatory processes. In contrast,
Lourenço etal. (2019), observed that C. albicans and C. glabrata susceptibility to
azole antifungal drugs is regulated by the vagina’s acidity level. Furthermore,
research into pH signalling mechanisms in Candida species other than albicans is
required.
+
amid
4
+
in
4
6.10 Effective Reactions toVarious Stress
Yeast cells need to be resilient to attach, proliferate, go through morphogenesis,
penetrate the tissues, and spread infection. Oxidative stress, osmotic stress, nutritional stress, temperature stress, along with pH-related stress are some of the stresses
that yeast cells face. It is also believed that host defense systems are a type of stress.
An immune response can produce ROS, which can cause oxidative stress and potentially starve yeast cells of nutrients. The likelihood of pathogen proliferation, tissue
invasion, and survival can all be reduced by the recruitment of neutrophils, basophils, cytokines, chemokines, and even complement proteins. Candida uses signalling pathways, including MAPK, Hog1, and MKC1 pathways, to react to different
stress stimuli. Among the TFs that control Candida’s stress response are Cap1,
Skn7, and Msn4 (Brown etal. 2014). Hsf1, Cta4, Cap1, and Skn7 are directly
Соседние файлы в папке Библиотека им академика М.И. Перельмана
